PUBLISHER: Grand View Research | PRODUCT CODE: 1321476
PUBLISHER: Grand View Research | PRODUCT CODE: 1321476
The global surgical instrument tracking systems market size is anticipated to reach USD 513.1 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 12.4% from 2023 to 2030. The increasing need for inventory management and the implementation of Unique Device Identification (UDI) regulations are some of the major factors supporting the market growth. Furthermore, surgical tool manufacturers are expected to track their products from manufacturing to distribution. The goal of device tracking is to ensure that instrument manufacturers set up mechanisms that allow them to locate devices in commercial distribution quickly. On July 22, 2022, the U.S. Food and Drug Administration (FDA) introduced the UDI system to track medical devices in the U.S. throughout the entire supply chain, from manufacturing to distribution to patient use.
The implementation of the UDI regulations is expected to create strong growth opportunities for the market. According to the guidelines, UDI labeling must be conducted by relevant stakeholders, including manufacturers, specification developers, re-packagers, re-labelers, and reprocessors at the individual instrument level. Surgical instrument tracking systems also enable better monitoring by competent authorities while reducing medical errors, thus propelling the demand. The usability of such solutions in inventory management and during the work cycle, including surgeries, storage, sterilization procedures, and post-surgery, are other drivers contributing to market growth. For instance, in April 2023, Northern Digital Inc. introduced the Polaris Lyra.
It is a compact optical tracker for tracking instruments in clinical & surgical suites and is designed for precise procedures using smaller instruments, with a high measurement rate and accuracy for real-time tracking and visualization. COVID-19 significantly impacted the market. The high risk of COVID-19 transmission in ORs, surgery suspension, and the declining rate of surgeries impacted the market. Although the number of elective surgeries plunged during the COVID-19 pandemic, the volume is expected to return to pre-COVID numbers, which is estimated to drive market growth. Also, the pandemic has highlighted the need for surgical instrument-tracking systems to track and control infections at hospitals and safeguard patient health.